TXN Earnings Arrive as Analysts Trim and Options Turn Cautious

Texas Instruments reported Q3 results on October 21, capping a week in which the stock slipped 3.5% to $277.78 and analysts moved to cut price targets just ahead of the release.

The most actionable development this week came from the Street. Wells Fargo trimmed its target from $310 to $300 on October 20, maintaining an Equal-Weight rating. TD Cowen followed a day earlier, cutting from $340 to $330 while keeping its Buy. Both moves land as earnings-season recalibrations rather than conviction shifts, but the direction is consistent: the consensus mean target now stands at $331, implying roughly 19% upside from current levels, yet the most recent analyst actions are pointed lower. That gap between the mean target and the direction of fresh revisions captures the Street's divided posture on TXN right now. JPMorgan (Overweight, $340) and Morgan Stanley (Underweight, $255) define the poles of the debate; the bull case rests on durable upcycle demand from industrial, automotive, and data centre customers, while bears focus on market share pressure in the core analog and embedded businesses that generate around 90% of revenue.

Options positioning backed that caution up. The put/call ratio reached 0.83 on October 20, about 1.9 standard deviations above its 20-day average of 0.78. That is the most defensive options read in the past month, and the move built steadily through the week as the earnings date approached. For context, the 52-week high on the PCR is 1.05, so current positioning is elevated but not extreme. The borrow market adds nothing to the short-side story: short interest at 2.2% of the free float is low and has drifted roughly flat over the past month. Availability remains essentially uncapped, and cost to borrow at 0.31% is trivial. There is no lending-market pressure in either direction.

Among its closest peers, TXN's weekly decline of 3.5% was broadly in line with the sector. ADI fell 4.3% on the week and MPWR dropped 5.4%, while NXPI bucked the group with a 5% gain and MCHP added 2.3%. European peers were weaker: IFX lost 7.1% and STMPA fell 6.5%. TXN's relative performance sits roughly in the middle of that range, neither a notable laggard nor a standout, which fits a stock where the earnings outcome rather than pre-positioning is the live variable.

The factor picture tilts modestly constructive on the non-price dimensions. The dividend score ranks in the 95th percentile, and days-to-cover ranks in the 81st percentile, reflecting the low short interest relative to trading volume. EPS momentum over 90 days sits at the 61st percentile, a recovery from a difficult 2025 but not yet a strong reading in absolute terms. The short score of 32.65 has been essentially flat for the past two weeks, consistent with an unchanged borrowing picture.

Insider activity over the past 90 days produced a net sale of roughly 7,000 shares worth $1.85 million, primarily an option exercise and subsequent sale by a senior vice president in late August. That is compensation-related mechanics rather than a discretionary bearish signal, and the values are small relative to the company's $252 billion market cap.

The most meaningful variable now is whether the Q3 print confirms or challenges the Q2 narrative of broadening recovery: the options market's modest defensive tilt going in reflected real uncertainty, and the analyst target cuts on the eve of results suggest even supporters were managing their expectations downward.